Search Results - "Hillegass, L M"

Refine Results
  1. 1

    Reperfusion increases neutrophils and leukotriene B4 receptor binding in rat focal ischemia by Barone, F C, Schmidt, D B, Hillegass, L M, Price, W J, White, R F, Feuerstein, G Z, Clark, R K, Lee, E V, Griswold, D E, Sarau, H M

    Published in Stroke (1970) (01-09-1992)
    “…Neutrophils are critically involved with ischemia and reperfusion injury in many tissues but have not been studied under conditions of reperfusion after focal…”
    Get full text
    Journal Article
  2. 2

    Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification by Barone, F C, Hillegass, L M, Price, W J, White, R F, Lee, E V, Feuerstein, G Z, Sarau, H M, Clark, R K, Griswold, D E

    Published in Journal of neuroscience research (01-07-1991)
    “…Two different techniques were utilized to identify the infiltration of polymorphonuclear leukocytes (PMN) into cerebral tissue following focal ischemia:…”
    Get more information
    Journal Article
  3. 3

    ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats by Rabinovici, R, Bugelski, P J, Esser, K M, Hillegass, L M, Vernick, J, Feuerstein, G

    Published in Journal of applied physiology (1985) (01-04-1993)
    “…We recently reported that the combined administration of lipopolysaccharide (LPS) and platelet-activating factor (PAF) in rats, at doses that are completely…”
    Get more information
    Journal Article
  4. 4

    Role of complement in endotoxin/platelet-activating factor-induced lung injury by Rabinovici, R, Yeh, CG, Hillegass, LM, Griswold, DE, DiMartino, MJ, Vernick, J, Fong, KL, Feuerstein, G

    Published in The Journal of immunology (1950) (01-09-1992)
    “…C receptor-1 is a protein involved in the regulation of C3 and C5-convertases. Recombinant human soluble C receptor-1 has recently been produced and shown to…”
    Get full text
    Journal Article
  5. 5

    Temporal relation between neutrophil accumulation and myocardial reperfusion injury by Smith, 3rd, E F, Egan, J W, Bugelski, P J, Hillegass, L M, Hill, D E, Griswold, D E

    Published in The American journal of physiology (01-11-1988)
    “…Infiltration of polymorphonuclear leukocytes (PMN) is associated with the progression of myocardial infarction and reperfusion injury. However, little is known…”
    Get full text
    Journal Article
  6. 6

    Priming by Platelet-Activating Factor of Endotoxin-Induced Lung Injury and Cardiovascular Shock by Rabinovici, Reuven, Esser, Klaus M, Lysko, Paul G, Yue, Tian-Li, Griswold, Don E, Hillegass, Leonard M, Bugelski, Peter J, Hallenbeck, John M, Feuerstein, Giora

    Published in Circulation research (01-07-1991)
    “…Platelet-activating factor (PAF) is a glycerophospholipid known for its unusual potent vasoactive and proinflammatory activities. The present study examined…”
    Get full text
    Journal Article
  7. 7

    Tumor necrosis factor-alpha mediates endotoxin-induced lung injury in platelet activating factor-primed rats by Rabinovici, R, Bugelski, P J, Esser, K M, Hillegass, L M, Griswold, D E, Vernick, J, Feuerstein, G

    “…We have reported recently that lipopolysaccharide endotoxin and platelet activating factor cooperate in priming relationships to elicit lung microvascular…”
    Get more information
    Journal Article
  8. 8

    Evaluation of human cytokine production and effects of pharmacological agents in a heterologous system in vivo by Griswold, D.E., Hillegass, L.M., O'Leary-Bartus, J., Lee, J.C., Laydon, J.T., Torphy, T.J.

    Published in Journal of immunological methods (09-09-1996)
    “…The ability of human monocytes adoptively transferred into the peritoneal cavity of BALB c mice to produce tumor necrosis factor-α (TNF) and interleukin 1β…”
    Get full text
    Journal Article
  9. 9

    Reduction of myocardial reperfusion injury with human soluble complement receptor type 1 (BRL 55730) by Smith, 3rd, E F, Griswold, D E, Egan, J W, Hillegass, L M, Smith, R A, Hibbs, M J, Gagnon, R C

    Published in European journal of pharmacology (04-06-1993)
    “…This study was designed to evaluate the cardioprotective effects of a solubilized human complement receptor, sCR1, in the rat subjected to myocardial…”
    Get more information
    Journal Article
  10. 10

    Induction of plasma exudation and inflammatory cell infiltration by leukotriene C4 and leukotriene B4 in mouse peritonitis by GRISWOLD, D. E, WEBB, E. F, HILLEGASS, L. M

    Published in Inflammation (01-08-1991)
    “…Leukotriene induction of the fluid and cellular phases of the inflammatory response in the mouse was evaluated. Intraperitoneal injection of leukotriene C4…”
    Get full text
    Journal Article
  11. 11

    Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505 by Smith, 3rd, E F, Griswold, D E, Egan, J W, Hillegass, L M, DiMartino, M J

    Published in Journal of cardiovascular pharmacology (01-05-1989)
    “…This study was designed to assess the effect of the thromboxane receptor antagonist, BM 13.505, in limiting myocardial damage and polymorphonuclear leukocyte…”
    Get more information
    Journal Article
  12. 12

    Reduction in myocardial ischemic/reperfusion injury and neutrophil accumulation after therapeutic administration of streptokinase by Smith, 3rd, E F, Nichols, A J, Sellers, T S, O'Brien, S R, Griswold, D E, Egan, J W, Hillegass, L M, Vasko, J A, Slivjak, M J, Davis, P A

    Published in Journal of cardiovascular pharmacology (01-11-1991)
    “…The benefit of thrombolytic agents to reduce myocardial infarct size, improve left ventricular (LV) function, and prolong survival in human subjects is…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Assessment of myeloperoxidase activity in whole rat kidney by Hillegass, L M, Griswold, D E, Brickson, B, Albrightson-Winslow, C

    Published in Journal of pharmacological methods (01-12-1990)
    “…A method to quantitate myeloperoxidase (MPO) activity from rat whole kidney is described. Polymorphonuclear leukocyte (PMN) infiltration into tissue is a…”
    Get more information
    Journal Article
  15. 15

    Tetrahydrothiadiazoloisoquinolines: synthesis and inhibition of phenylethanolamine-N-methyltransferase by GIRARD, G. R, BONDINELL, W. E, HILLEGASS, L. M, HOLDEN, K. G, PENDLETON, R. G, UZINSKAS, I

    Published in Journal of medicinal chemistry (01-07-1989)
    “…A series of 7,8-fused heterocyclic tetrahydroisoquinolines were synthesized and tested as inhibitors of rabbit adrenal phenylethanolamine-N-methyltransferase…”
    Get full text
    Journal Article
  16. 16

    Inhibitors of phenylethanolamine N-methyltransferase and epinephrine biosynthesis. 3. Bis[tetrahydroisoquinoline]s by DeMarinis, R. M, Bryan, W. M, Hillegass, L. M, McDermott, D, Pendleton, R. G

    Published in Journal of medicinal chemistry (01-06-1981)
    “…7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline (SK&F 64139) is a potent inhibitor of phenylethanolamine N-methyltransferase (IC50 = 10 muM) that may have…”
    Get full text
    Journal Article
  17. 17

    Time-related changes in myeloperoxidase activity and leukotriene B4 receptor binding reflect leukocyte influx in cerebral focal stroke by Barone, F C, Hillegass, L M, Tzimas, M N, Schmidt, D B, Foley, J J, White, R F, Price, W J, Feuerstein, G Z, Clark, R K, Griswold, D E

    Published in Molecular and chemical neuropathology (01-01-1995)
    “…In previous studies, we have used histological methods to characterize cellular changes, and validated the use of the myeloperoxidase (MPO) activity assay to…”
    Get full text
    Journal Article
  18. 18

    Method for quantification of myocardial infarction and inflammatory cell infiltration in rat cardiac tissue by Griswold, D E, Hillegass, L M, Hill, D E, Egan, J W, Smith, 3rd, E F

    Published in Journal of pharmacological methods (01-11-1988)
    “…A method to quantitate both creatine phosphokinase (CPK) and myeloperoxidase (MPO) activity from the same cardiac tissue homogenate preparation is described…”
    Get more information
    Journal Article
  19. 19

    Pharmacology of the pyrroloimidazole, SK&F 105809--II. Antiinflammatory activity and inhibition of mediator production in vivo by Griswold, D E, Marshall, P J, Lee, J C, Webb, E F, Hillegass, L M, Wartell, J, Newton, Jr, J, Hanna, N

    Published in Biochemical pharmacology (25-07-1991)
    “…SK&F 105809 [2-(4-methylsulfinylphenyl)-3-(4-pyridyl)- 6,7-dihydro-[5H]-pyrrolo[1,2,a] imidazole] demonstrated unique antiinflammatory activities in murine…”
    Get more information
    Journal Article
  20. 20